Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

NCT01687712 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1100

Enrollment

INDUSTRY

Sponsor class

Conditions

Infertility

Interventions

DRUG: AFOLIA
DRUG: Gonal-f® RFF

Sponsor

Fertility Biotech AG